-
SLRX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Salarius Pharmaceuticals (SLRX)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 3.28 mm | 3.28 mm | 3.28 mm | 3.28 mm | 3.28 mm | 3.28 mm |
Cash burn (monthly) | (no burn) | 358.05 k | 335.49 k | 434.69 k | 452.22 k | 441.17 k |
Cash used (since last report) | n/a | 1.81 mm | 1.70 mm | 2.20 mm | 2.29 mm | 2.23 mm |
Cash remaining | n/a | 1.47 mm | 1.58 mm | 1.08 mm | 993.63 k | 1.05 mm |
Runway (months of cash) | n/a | 4.1 | 4.7 | 2.5 | 2.2 | 2.4 |
13F holders | Current |
---|---|
Total holders | 7 |
Opened positions | 4 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 4.46 mm |
Total shares | 3.87 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Lincoln Park Capital Fund | 2.97 mm | $802.00 k |
CVI Investments | 804.35 k | $732.00 k |
Lind Global Fund II | 89.09 k | $0.00 |
C Citigroup | 1.61 k | $2.32 mm |
UBS UBS | 260.00 | $375.00 k |
Advisor | 162.00 | $232.00 k |
BlackRock | 1.00 | $1.00 k |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Apr 24 | Arthur David J. | Stock Option Common Stock | Grant | Acquire A | No | No | 0.51 | 20,500 | 10.46 k | 20,500 |
20 Feb 24 | Rosenblum Mark J | Stock Option Common Stock | Grant | Acquire A | No | No | 0.5711 | 22,500 | 12.85 k | 22,500 |
20 Feb 24 | McVicar William K. | Stock Option Common Stock | Grant | Acquire A | No | No | 0.5711 | 20,500 | 11.71 k | 20,500 |
20 Feb 24 | Lieber Jonathan I | Stock Option Common Stock | Grant | Acquire A | No | No | 0.5711 | 20,500 | 11.71 k | 20,500 |
20 Feb 24 | McCreedy Bruce J Jr. | Stock Option Common Stock | Grant | Acquire A | No | No | 0.5711 | 20,500 | 11.71 k | 20,500 |